Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxisome proliferator-activated receptor (PPAR) activators, thiazolidinediones, (TZDs), are insulin sensitizers used as a treatment for NAFLD. However, TZDs are a controversial treatment for NAFLD because...

Descripción completa

Detalles Bibliográficos
Autores principales: Choung, Sorim, Joung, Kyong Hye, You, Bo Ram, Park, Sang Ki, Kim, Hyun Jin, Ku, Bon Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020545/
https://www.ncbi.nlm.nih.gov/pubmed/30008738
http://dx.doi.org/10.1155/2018/4292509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020545/
https://www.ncbi.nlm.nih.gov/pubmed/30008738
http://dx.doi.org/10.1155/2018/4292509

Ejemplares similares